Immune checkpoint inhibitors: A potential bright spot in the treatment of progressive multifocal leukoencephalopathy

Related Experiment Video

Updated: Aug 19, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.4K

Jeremias Motte1, Ralf Gold1

  • 1Department of Neurology, St. Josef-Hospital, Ruhr University Bochum, Bochum, Germany.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|December 1, 2022
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Multiple sclerosiscommentfingolimodpembrolizumabprogressive multifocal leukoencephalopathy

More Related Videos

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

935
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.8K

Related Concept Videos